|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Ribapharm
Inc.'s December 31, 1999 Consolidated Condensed Financial Statements and is
qualified in its entirety by reference to such Financial Statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> DEC-31-1999
<CASH> 0
<SECURITIES> 0
<RECEIVABLES> 34,462
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 34,462
<PP&E> 24,379
<DEPRECIATION> (3,664)
<TOTAL-ASSETS> 55,177
<CURRENT-LIABILITIES> 1,112
<BONDS> 0
0
0
<COMMON> 0
<OTHER-SE> 51,400
<TOTAL-LIABILITY-AND-EQUITY> 55,177
<SALES> 0
<TOTAL-REVENUES> 109,592
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 5,523
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 396
<INCOME-PRETAX> 98,065
<INCOME-TAX> 35,303
<INCOME-CONTINUING> 62,762
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 62,762
<EPS-BASIC> 0
<EPS-DILUTED> 0
</TABLE>
|
|